Cameron R. Wolfe MD
Clinical Associate in the Department of Medicine, Duke University School of Medicine
Join to View Full Profile
2301 Erwin RdDurham, NC 27705
Phone+1 919-681-9660
Fax+1 919-620-4921
Dr. Wolfe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 2007 - 2009
University of Melbourne Faculty of MedicineClass of 2000
Certifications & Licensure
NC State Medical License 2007 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Respiratory Virus Hospitalization Study (FLU 003 Plus)
- Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- The tell-tale hearts: Donor-derived invasive fungal infections among orthotopic heart transplant recipients.Jay Krishnan, Manuela Carugati, Rachel A Miller, Cameron R Wolfe, John R Perfect
Medical Mycology Case Reports. 2025-06-01 - Outcomes of lung transplantation from SARS-CoV-2 positive donors during the Omicron wave.Sonya M Kothadia, Cameron R Wolfe, Arthur W Baker, Katherine A Young, John M Reynolds
JHLT Open. 2025-05-01 - Antiviral Trials-Navigating the Shifting Sands of a Pandemic.Beatrice Z Sim, Cameron R Wolfe
Clinical Infectious Diseases. 2025-02-17
Journal Articles
- Emergency Use Authorization of RemdesivirMichael G Ison, Cameron Wolfe, Helen W Boucher, JAMA
- Maximizing Utilization of the Donor Pool by Appropriate Classification of Hepatitis C Antibody Positive DonorsCameron R Wolfe, David S Goldberg, American journal of transplantation
Authored Content
- Emergency Use Authorization of RemdesivirMay 2020
Press Mentions
What We Still Don't Know About COVID-19 5 Years After the WHO Declared a PandemicMarch 11th, 2025- Measles Outbreak Hits Town in TexasFebruary 12th, 2025
- The Mosquito-Borne Virus Raising Alarms in the NortheastAugust 28th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
